Earnings Feed
Start Free
Home/Filings/4/0001225208-17-016030
4//SEC Filing

Bose Supratim 4

Accession 0001225208-17-016030

CIK 0000885725other
View on SEC.govCompany Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:16 PM ET

Size

32.6 KB

Accession

0001225208-17-016030

Insider Transaction Report

Form 4
Period: 2017-10-03
BOSTON SCIENTIFIC CORPBSX
Bose Supratim
EVP & President, Asia-Pacific
Transactions
  • Exercise/Conversion

    Common Stock

    2017-10-04$7.39/sh+88,071$650,845→ 408,372 total
  • Exercise/Conversion

    Common Stock

    2017-10-04$16.31/sh+15,086$246,053→ 462,717 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-03−174,672→ 0 total
    Exercise: $5.36Exp: 2022-01-03→ Common Stock (174,672 underlying)
  • Sale

    Common Stock

    2017-10-03$29.08/sh−196,817$5,723,222→ 320,301 total
  • Exercise/Conversion

    Common Stock

    2017-10-04$17.26/sh+7,904$136,423→ 470,621 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-03−22,145→ 15,352 total
    Exercise: $6.28Exp: 2022-02-27→ Common Stock (22,145 underlying)
  • Exercise/Conversion

    Common Stock

    2017-10-03$5.36/sh+174,672$936,242→ 494,973 total
  • Sale

    Common Stock

    2017-10-04$29.18/sh−150,320$4,386,338→ 320,301 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-04−15,086→ 15,086 total
    Exercise: $16.31Exp: 2025-02-23→ Common Stock (15,086 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-04−23,907→ 7,969 total
    Exercise: $13.08Exp: 2024-02-24→ Common Stock (23,907 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-04−15,352→ 0 total
    Exercise: $6.28Exp: 2022-02-27→ Common Stock (15,352 underlying)
  • Exercise/Conversion

    Common Stock

    2017-10-03$6.28/sh+22,145$139,071→ 517,118 total
  • Exercise/Conversion

    Common Stock

    2017-10-04$13.08/sh+23,907$312,704→ 432,279 total
  • Exercise/Conversion

    Common Stock

    2017-10-04$6.28/sh+15,352$96,411→ 447,631 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-04−7,904→ 23,714 total
    Exercise: $17.26Exp: 2026-02-22→ Common Stock (7,904 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-10-04−88,071→ 0 total
    Exercise: $7.39Exp: 2023-02-28→ Common Stock (88,071 underlying)
Footnotes (9)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
  • [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.4901, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.255, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on January 3, 2013, the first anniversary of the grant.
  • [F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
  • [F6]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
  • [F7]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
  • [F8]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
  • [F9]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

→
Entity typeother

Related Parties

1
  • filerCIK 0001538431

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:16 PM ET
Size
32.6 KB
View on SEC.gov